Wondering if we might be seeing a large investor about to underwrite phase 3 for her-vaxx.
realistically we either need to sell it in full or find some funds.
If the intention is to keep this through phase 3 in house then we will need a partner with deep pockets.
I would be favouring a non pharma related entity so that some form of independence is maintained which supports the “dance card” view of licensing the product to multiple pharmas.
my opinion only DYOR
Ann: Trading Halt, page-73
-
- There are more pages in this discussion • 342 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.003(5.36%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 6.1¢ | 5.6¢ | $1.239M | 21.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1459482 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 633310 | 6 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |